25.06.20 ijBio Portfolio

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 25.06.20:

AstraZeneca (AZN) $51,3 $53 (+3.3%) $103,300

Inovio (INO) $13,2 $31,2 (+136,4%) $236,400

Moderna (MRNA)$61,5 $62 (+0.8%) $108,000

Abbot (ABT) $88,5 $89,6 (+1.2%) $101,200

Gilead (GILD) $72,5 $75,5 (+4.1%) $104,100

Adaptive (ADPT) $42,2 $47,2 (+11.8%) $111,800

CytoDyn (CYDY) $3,12 $6,15 (+97.1%) $197,100

AbbVie (ABBV) $92,2 $97 (+5.2%) $105,200

Arcus (RCUS) $27,3 $24,3 (-11%) $89,000

Sorrento (SRNE) $4,6 $6,35 (+38%) $138,000

At close 25.06.20= $1,294,100 (+10,3%)

per million dollars at 10% per share.

previous day

At close 24.06.20= $1,172,600 (+3%)

-

At close 19.06.20= $1,057,700

during the week 12-19.06 +3%

12.06.20 = $1,000,000

Global Communication Platforms portfoilio

--

Portfolio News:

Covid-19 Complications, Grocery Store-y, More on Moderna: Market Recon

Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed

These 6 health-care stocks are ‘buys’ because they can thrive under either Trump or Biden

Exclusive: Sanofi planning to cut up to 1,680 jobs in Europe

Exclusive: Sanofi considering up to 1,680 job cuts in Europe - sources

Daiichi Sankyo in talks with AstraZeneca on virus vaccine supply in Japan

Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol

Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm

Bayer Isn’t Out of the Roundup Woods as 30,000 Claims Remain

Acquiring Biomarin Would Speed Sanofi Transition to New Therapies

How gene therapy and CRISPR are helping to cure blindness

Moderna Partners With Catalent For First 100 Million Covid-19 Vaccine Doses In Q3

Moderna, Catalent Collaborate On Coronavirus Vaccine Manufacturing Capacity

Covid-Linked Stocks Rally on Trump’s ‘Surprise’ Hint, Day Trades

Vaccine Maker ETF Climbs on Trump's Positive Proclamation

The Zacks Analyst Blog Highlights: LLY, ABBV, NBIX and RDY

Pfizer Declares Third-Quarter 2020 Dividend

These 6 health-care stocks are ‘buys’ because they can thrive under either Trump or Biden

Moderna Is the Latest Coronavirus Vaccine Partner for Catalent

Is Moderna (MRNA) Outperforming Other Medical Stocks This Year?

Many studies of COVID-19 antibody test accuracy fall short - review

NanoViricides: Sufficient Funding for Covid-19 Research

• Yahoo Finance

Advertise With Us

© 2020 Verizon Media. All rights reserved.

Data DisclaimerHelpSuggestions

Privacy (Updated)About Our AdsTerms (Updated)Sitemap

• Infojet Club